Biofrontera Inc.

Last updated September 27, 2026

Organization details

Legal name
Biofrontera Inc.
Ownership
Public
Status
Active
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
Woburn
Headquarters state / province
Massachusetts
Headquarters country
United States
Fiscal year end
December
Ticker symbol
BFRI
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001858685
EIN
47-3765675

Board of directors

Chief executives

Hermann Luebbert · CEO & Exec. Chairman
Dates unknown

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Jul 28, 2026 Leffler Eugene Frederick Officer (Chief Financial Officer) Option exercise +31,250 — —
Jul 28, 2026 Hermann Luebbert Director, Officer (CEO & Chairman) Option exercise +62,500 — —
Mar 5, 2026 Hermann Luebbert Director, Officer (CEO & Chairman) Option exercise +137,500 — —
Mar 5, 2026 Leffler Eugene Frederick Officer (Chief Financial Officer) Option exercise +87,500 — —
Sep 10, 2025 Hermann Luebbert Director, Officer (CEO & Chairman) Option exercise +137,500 — —
Sep 10, 2025 Leffler Eugene Frederick Officer (Chief Financial Officer) Option exercise +87,500 — —
May 18, 2024 Hermann Luebbert Director, Officer (CEO & Exec. Chairman) Option exercise +4,771 — —
May 18, 2023 Monaco Erica L. Officer (Chief Executive Officer) Option exercise +76,336 — —
May 18, 2023 Hermann Luebbert Director, Officer (Executive Chairman) Option exercise +95,420 — —

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.